Zimmer Biomet Stock Fair Value Calculation – Zimmer Biomet Holdings Showcases Visible Growth and Strong Execution

☀️Trending News

Zimmer Biomet ($NYSE:ZBH) Holdings is a leading global medical device manufacturer that designs and manufactures orthopedic implants and accessories. With a strong presence in the orthopedic industry, Zimmer Biomet has been steadily increasing its market share and growing its presence in the medical device sector. Recently, Zimmer Biomet Holdings has further demonstrated its success in executing its plans and achieving growth. The company has seen visible signs of growth in recent years, including an increase in revenues and profits. This can be attributed to the company’s successful execution of its strategy and its focus on delivering quality products and services.

Zimmer Biomet Holdings also recently announced plans to expand its international presence, which will further contribute to its growth and success. Overall, Zimmer Biomet Holdings has shown clear signs of growth and strong execution of its plans. Its commitment to providing quality products and services, as well as its plans for international expansion, make it a strong contender in the medical device sector.

Price History

Zimmer Biomet Holdings, Inc. had an impressive showing on Monday as the stock opened at $118.8 and closed at the same price, up by 0.1% from its previous closing price of $118.7. It has been able to maintain a steady trajectory of success even amidst the challenging economic landscape. The company has implemented several initiatives to ensure that it remains competitive in terms of both technology and innovation, and these have paid off for Zimmer Biomet Holdings in the form of long-term success.

It has consistently focused on delivering superior products and services to its customers, and this focus has driven its sustained growth and profitability over the years. The company’s strong execution is also evidenced by its ability to continually adjust its business model to meet the needs of its customers in a rapidly changing healthcare environment. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Zimmer Biomet. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Zimmer Biomet. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Zimmer Biomet. More…

Key Ratios Snapshot

Some of the financial key ratios for Zimmer Biomet are shown below. More…

Analysis – Zimmer Biomet Stock Fair Value Calculation

GoodWhale conducted an analysis of ZIMMER BIOMET‘s financials and our proprietary Valuation Line was used to calculate the fair value of the stock. According to our analysis, ZIMMER BIOMET is currently trading at a price of $118.8, which is overvalued by 24.2%. The fair value of ZIMMER BIOMET stock is estimated to be around $95.7. The current market trading price is more than the fair value, which means investors must be sure to conduct their own due diligence before investing in the stock. We advise investors to monitor ZIMMER BIOMET’s share price and research the company’s financials in order to make an informed decision about their investment. More…

Peers

The company operates in two segments, Reconstructive and Dental. It offers knee, hip, shoulder, elbow, hand and wrist, foot and ankle, and biologics products. The company also provides dental prosthetics, including dental implants and CAD/CAM systems; and digital equipment for dentists and laboratories. Zimmer Biomet has a market cap of $24.4 billion and is headquartered in Warsaw, Indiana.

– Alcon Inc ($LTS:0A0D)

Alcon Inc is a global medical company that specializes in eye care products and services. The company’s market cap as of 2022 is 30.09B, and its return on equity is 1.87%. Alcon’s products and services include contact lenses, intraocular lenses, ophthalmic surgical devices, and ophthalmic pharmaceuticals. The company has a presence in over 100 countries and serves customers in the retail, wholesale, and government sectors.

– Sonova Holding AG ($LTS:0QPY)

Sonova Holding AG is a Swiss manufacturer of hearing aids. The company was founded in 1947 and is headquartered in Zurich, Switzerland. As of 2020, Sonova Holding AG had a market cap of 15.37 billion Swiss francs and a return on equity of 18.9%. The company’s products are sold under the brand names Phonak, Unitron, and Advanced Bionics. Sonova Holding AG’s products are available in more than 100 countries.

– Tandem Diabetes Care Inc ($NASDAQ:TNDM)

Tandem Diabetes Care Inc is a medical device company that develops, manufactures and sells insulin pumps for people with diabetes. The company has a market cap of $2.56 billion and a return on equity of -8.79%. Tandem’s products include the t:slim X2 insulin pump, the t:flex insulin pump, and the t:slim G4 insulin pump. The company also offers the t:lock Connectivity System, a cloud-based software platform that allows users to manage their diabetes devices and data.

Summary

Zimmer Biomet is a global leader in musculoskeletal healthcare, offering a complete portfolio of orthopedic products. The company has seen strong growth due to a shift towards more value-based and cost-effective care, improved operating margins, and increasing product sales. Its focus on innovation and new product development has also been beneficial, as it continues to develop customized solutions for a wide range of patient needs. Improving patient outcomes and driving data-driven decisions are part of its strategy going forward.

Its strong balance sheet and cash flows provide further potential for growth. With attractive valuations and long-term growth prospects, Zimmer Biomet looks to be an attractive investing opportunity.